MSK diseases Flashcards
pathophysiology of MG
IgG antibodies destroy post junctional nicotinic Ach receptors at NMJ
-aka theres enough Ach just not enough functional receptors which is why it presents as skeletal muscle weakness
key feature of MG
gets worse throughout day or after exercise. rest allows for recovery
surgical option for MG
thymus gland plays a role and a thymectomy brings relief to patients
sx of MG
(earliest: 2)
earliest signs: diplopia, ptosis
bulbar muscle weakness (muscles of mouth and throat). dysphagia, dysarthria, difficulty handling saliva. dyspnea with exertion, proximal muscle weakness.
situations that exacerbate sx of MG (5)
pregnancy
infection
electrolyte abnormalities**
surgical and psychological stress
aminoglycoside abx**
MG antibodies and neonates
(including how long it lasts)
anti AchR IgG antibodies cross placenta and cause weakness in 15-20% of neonates.
-can persist for up to 2-4 weeks, consistent with half life of these antibodies
-neonates may need aw management
tx for MG (4)
-anticholinesterases: PO pyridostigmine is first line
-immunosuppression: corticosteroids, cyclosporine, azathioprine, mycophenolate
-surgery: thymectomy (reduces anti AchR IgG- median sternotomy OR trans cervical approach)
-plasmapharesis: temporary relief for MG crisis before thymectomy
MG and pyridostigmine OD (cholinergic crisis) sx, dx, tx
-pt with MG on pyridostigmine becomes acutely weak
-dx via tensilon test (edrophonium 1-2mg IV). if sx get worse, patient is in cholinergic crisis–> tx with anticholinergics
if sx improve, patient had MG crisis
MG and ND NMB’s
increased sensitivity
-potency is increased so reduce dose by 1/2-2/3
MG and depolarizing NMB’s
decreased sensitivity
-if RSI required, dose should be 1.5-2mg
-since pyridostigmine is mainstay of medical management, it descreases pseudocholinesterase and increases DOA of succ
postop concerns for a patient with MG
- residual NMB/muscle weakness
- bulbar dysfunction- difficulty handling PO secretions
- educate on plausible need for postop MV and what increases their risk (disease duration >6y, daily pyridostigmine >750mg/day, VC <2.9L, COPD, if the surgical approach was the median sternotomy> trans cervical thymectomy
lambert eaton syndrome or LEMS pathophysiology
-IgG mediated destruction of presynaptic Vg Ca channels at the pre synaptic nerve terminal
-for this reason, Ca entry via depol is limited and so is Ach released into synaptic cleft
-post synaptic nicotinic receptor is present in normal quantity and functions normally
clinical presentation of LEMS
-proximal muscles are most affected and weakness is worst in the AM but gets better throughout the day (probs because more Ach can say hello)
-resp musculature and diaphragm become weak
-ANS dysfunction causes orthostatic HoTN, slowed gastric mobility, urinary retention
LEMS tx
3,4 diaminpyridine (DAP) increases Ach release from presynaptic nerve terminal and improves strength of contraction.
-acetylcholinesterase are not helpful and tensilon test does not aid in dx
anesthetic considerations for LEMS patient
-reversal with acetylcholinesterase may be inadequate despite proper dosing
-at high risk for postop vent failure
-~60% of LEMS patients have small cell (oat cell) carcinoma of lung.
LEMS response to succ
sensitive
LEMS response to ND NMB’s
sensitive
Guillian Barre syndrome
aka acute idiopathic polyneuritis
-immunologic assault on myelin in peripheral nerves
-AP cant be conducted to motor end plate never receives the signal
clinical presentation of Guillian barre (acute idiopathic polyneuritis)
-flu like illness usually precedes paralysis by 1-3w
-GBS usually persists for 2 weeks with full recovery in ~4w
-about 2% affected with GBS will develop chronic inflammatory demyelinating polyneuropathy
common etiologies of Guillian barre
campylobacter jejuni bacteria, epstein barr, and cytomegalovirus. other causes include vaccines, surgery, and lymphomatous disease
s/sx of GBS
-flaccid paralysis begins in distal extremities and ascends bilaterally towards proximal extremities, trunk, and face
-intercostal muscle weakness impairs ventilation
-facial and pharyngeal weakness causes difficulty swallowing
-sensory deficits include parasthesias, numbness, and pain
-autonomic dysfx is common- tachycardia or bradycardia, HTN or HoTN, diaphoresis or anhidrosis, orthostatic HoTN
tx of GBS
plasmapheresis and IV IgG
(-in contrast to MS, steroids and interferon do not improve this condition)
anesthetic considerations for GBS
(resp, steroids?, adrenergic drugs, type of anesthesia)
-facial and pharyngeal weakness causes difficulty swallowing and increases risk of aspiration
-may require postop MV
-with autonomic dysfunction youre at risk for hemodynamic variability and should do aline
- exaggerated response to indirect sympathomimetics due to up regulation of post junctional adrenergic receptors
-regional anesthesia is controversial
-steroids are not useful
-immobility increases risk of DVT
succ and GBS
sensitive, avoid. up regulation of post junctional receptors
ND NMB’s and GBS
increased sensitivity
is familial periodic paralysis a disease of the NMJ
no its a DO of the skeletal muscle membrane (reduced excitability)
hypokalemic periodic paralysis is associated with which type of channelopathy
calcium
dx of hypokalemic periodic paralysis
present if skeletal muscle weakness follows a glucose insulin infusion. patient becomes weak as serum k decreases
dx of hyperkalemic periodic paralysis
if skeletal muscle weakness follows PO potassium administration.
tx for either hyper or hypokalemic periodic paralysis
acetazolamide. creates non anion gap acidosis (HCO3- fall is matched by Cl- rise) which protects against hypokalemia while facilitating renal K excretion which guards against hyperkalemia
anesthetics considerations for familial periodic paralysis: temperature
hypothermia avoided at all costs. normothermia even on CPB bro
with hypokalemic periodic paralysis, what drugs are safe to administer
non depolarizers, acetazolamide
with hypokalemic periodic paralysis, what drugs are NOT safe to administer (4)
glucose containing solutions
K wasting diuretics
B2 agonists
succ
with hyperkalemic periodic paralysis, what drugs are safe to administer (5)
glucose containing solutions
K wasting diuretics
B2 agonists
non depolarizers
acetazolamide
with hyperkalemic periodic paralysis, what drugs are NOT safe to administer (2)
succ
K containing solutions
hypokalemic periodic paralysis and succ
association between this and MH, dont admin
hyperkalemic periodic paralysis and succ
no association with MH BUT at much higher risk for hyperkalemic issues r/t succ
ND NMB’s and familial periodic paralysis
slight increased sensitivity but safe to use. use shorter acting if possible
2 classes of drugs known to trigger MH
halogenated agents and depolarizing NMB’s
MH pathophys
- when T tubule is depolarized, Ca enters myocyte via dihydropyridine receptor
- activates defective receptor RYRY1, which instructs SR to release way too much Ca into cell.
- not only is there more Ca for contraction, SERCA2 pump is trying to pump Ca back in
- both increase O2 consumption, take a lot of ATP
- breakdown of sarcolemma allows K and myoglobin (toxic to the kidneys) to enter the system circulation
consequences of increased intra cellular calcium in myocyte
-rigidity from sustained contraction
-accelerated metabolic rate and rapid depletion of ATP
-increased O2 consumption
-increased CO2 and heat production
-mixed resp and lactic acidosis
-sarcolemma breaks down
-K and myoglobin leak into systemic circulation
3 diseases definitively associated with MH
- king den borough syndrome
- central core disease
- multi mini core disease
DMD in comparison to MH
absence of dystrophin destabilizes sarcolemma during muscle contraction and increases membrane permeability. This allows myoglobin to exit cell. Creates MH like syndrome but it is due to rhabdo not true MH
halogenated agents/depolarizing NMB’s and DMD
creates MH like syndrome (and really rhabdo) so still avoid
any DMD or muscular dystrophy who has cardiac arrest on induction should be treated as if
if its hyperkalemic and should receive CaCl immediately
conditions NOT associated with MH include (5)
Becker muscular dystrophy
neuroleptic malignant syndrome
myotonia congenita
myotonic dystrophy
osteogenesis imperfecta
factors that increase risk of MH include
- geography (families in wisconsin, nebraska, WV, michigan)
- male sex
- youth